An automated portable system for detecting and treating opioid induced respiratory depression
用于检测和治疗阿片类药物引起的呼吸抑制的自动化便携式系统
基本信息
- 批准号:10592367
- 负责人:
- 金额:$ 127.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcousticsAddressAnesthesiologyAnimal ModelBloodBrain DeathBrain InjuriesBreathingCellsCellular PhoneCessation of lifeClassificationClinical DataCollaborationsConsumptionDataDepressed moodDetectionDevicesDoseEngineeringExerciseExpert SystemsFailureFentanylHeart RateHumanIndividualInjectionsInterventionLettersMachine LearningMedicalMedicineMethodsMonitorMorphologic artifactsMotionMusNaloxoneNeedlesOpioidOutcomeOverdoseOxygenPatientsPatternPhysical activityPhysiologicalReal-Time SystemsResearchRespirationSleepSystemTherapeuticTherapeutic UsesTimeTrainingVariantVentilatory Depressionawakeclinical painconvolutional neural networkdetection platformdigitaldosagehuman dataimprovedinnovationmachine learning algorithmmouse modelnovelopioid overdoseportabilityprescription opioidprototyperespiratorysensortherapeutic opioidtherapeutic patchtranslation to humanstranslational applicationstranslational potentialuser-friendlywearable sensor technology
项目摘要
PROJECT SUMMARY
Opioid overdoses caused almost 70,000 deaths in the US in the year ending in November 2020. Many of these
occur during the therapeutic use of prescription opioids, particularly when consumption is erratic or among
workers from certain professions. Despite the promotion of naloxone for opioid overdose, the effective rescue of
an individual from an overdose during the therapeutic use of opioids is still very challenging for several reasons:
(1) the onset of an opioid overdose may be very difficult for the patient or their associates to rapidly recognize;
(2) the time between the onset of respiratory depression and irreversible brain damage or death is brief; leaving
a brief time window to seek medical help and intervene; and (3) methods employed by self- or bystanders to
treat an opioid overdose may not be available or are complicated for lay individuals to use. Thus, there is an
urgent and unmet need for real-time detection and automated treatment of opioid overdose, even during the
therapeutic use of opioids. The overall objective of this U01 application is to develop an automated portable
system to detect and treat an opioid overdose in real time. The research team pursues engineering advances in
developing wearable sensors for real-time tracking of multiple physiological parameters and therapeutic patches
for precise transdermal delivery of naloxone, respectively. The proposed project will further develop wearable
sensors to track the variation of physiological parameters (e.g., breathing pattern, blood oxygen level, and heart
rate) for the real-time detection of an opioid overdose. The proposed project also aims to optimize novel acoustic
patches to deliver naloxone for treating an opioid overdose. A closed-loop system will be established through
integration of a wearable sensor, a therapeutic patch, a machine learning-based controller driven by a cell phone.
The proposed system will be validated using a mouse model of opioid overdose well developed in the PI’s lab,
and adapted for the potential translational applications in human patients. The ultimate product of this study is
to construct a prototype system for real-time detection and automated treatment of an opioid overdose.
项目概要
截至 2020 年 11 月的一年中,阿片类药物过量导致美国近 70,000 人死亡。其中许多人死亡
发生在处方阿片类药物的治疗使用过程中,特别是当用量不稳定或在使用处方阿片类药物时
尽管提倡使用纳洛酮治疗阿片类药物过量,但仍能有效挽救某些职业的工人。
由于以下几个原因,在阿片类药物治疗期间过量服用的个体仍然非常具有挑战性:
(1) 患者或其同伴可能很难迅速识别阿片类药物过量的发生;
(2) 呼吸抑制发生与不可逆的脑损伤或死亡之间的时间很短;
寻求医疗帮助和干预的短暂时间窗口;以及 (3) 自我或旁观者采用的方法
治疗阿片类药物过量可能无法实现,或者对于非专业人士来说使用起来很复杂,因此,有一种方法。
即使在阿片类药物过量的情况下,对实时检测和自动治疗的迫切且未满足的需求
该 U01 应用程序的总体目标是开发一种自动化便携式药物。
实时检测和治疗阿片类药物过量的系统 该研究团队追求工程进步。
开发可穿戴传感器,用于实时跟踪多个生理参数和治疗贴片
分别用于纳洛酮的精确透皮输送。拟议的项目将进一步开发可穿戴设备。
传感器跟踪生理参数的变化(例如呼吸模式、血氧水平和心率)
率)用于实时检测阿片类药物过量该项目还旨在优化新型声学。
提供纳洛酮的贴剂用于治疗阿片类药物过量,将建立闭环系统。
集成了可穿戴传感器、治疗贴片、由手机驱动的基于机器学习的控制器。
所提出的系统将使用 PI 实验室开发的阿片类药物过量小鼠模型进行验证,
并适应人类患者的潜在转化应用这项研究的最终产品是。
构建一个实时检测和自动治疗阿片类药物过量的原型系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Feng Guo其他文献
Feng Guo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Feng Guo', 18)}}的其他基金
An automated portable system for detecting and treating opioid induced respiratory depression
用于检测和治疗阿片类药物引起的呼吸抑制的自动化便携式系统
- 批准号:
10478481 - 财政年份:2022
- 资助金额:
$ 127.81万 - 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
- 批准号:
10645137 - 财政年份:2021
- 资助金额:
$ 127.81万 - 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
- 批准号:
10280762 - 财政年份:2021
- 资助金额:
$ 127.81万 - 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
- 批准号:
10453620 - 财政年份:2021
- 资助金额:
$ 127.81万 - 项目类别:
Acoustic assembly of patient tumor organoids for modeling cancer immunity
用于模拟癌症免疫的患者肿瘤类器官的声学组装
- 批准号:
10187568 - 财政年份:2020
- 资助金额:
$ 127.81万 - 项目类别:
An acoustofluidic avidity cytometer for massive parallel profiling single autoreactive T cell in autoimmune disease
用于大规模平行分析自身免疫性疾病中单个自身反应性 T 细胞的声流控亲和细胞仪
- 批准号:
10002377 - 财政年份:2020
- 资助金额:
$ 127.81万 - 项目类别:
Acoustic assembly of patient tumor organoids for modeling cancer immunity
用于模拟癌症免疫的患者肿瘤类器官的声学组装
- 批准号:
10041819 - 财政年份:2020
- 资助金额:
$ 127.81万 - 项目类别:
STRUCTURE OF THE DIMERIZATION DOMAIN OF DIGEORGE CRITICAL REGION 8
DIGEORGE关键区8的二聚化结构域的结构
- 批准号:
8361692 - 财政年份:2011
- 资助金额:
$ 127.81万 - 项目类别:
Molecular recognition and regulation in microRNA processing by the DGCR8 protein
DGCR8 蛋白对 microRNA 加工的分子识别和调控
- 批准号:
7628447 - 财政年份:2007
- 资助金额:
$ 127.81万 - 项目类别:
Molecular recognition and regulation in microRNA processing by the DGCR8 protein
DGCR8 蛋白对 microRNA 加工的分子识别和调控
- 批准号:
7322279 - 财政年份:2007
- 资助金额:
$ 127.81万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 127.81万 - 项目类别:
Preventing the Transition from Acute to Chronic Musculoskeletal Pain in Adolescents after Surgery: The Role of Sleep
防止青少年手术后从急性肌肉骨骼疼痛转变为慢性肌肉骨骼疼痛:睡眠的作用
- 批准号:
10879417 - 财政年份:2023
- 资助金额:
$ 127.81万 - 项目类别:
Restoring Endothelial Function After Traumatic Injury to Reduce ARDS and Multi-Organ Dysfunction
创伤性损伤后恢复内皮功能以减少 ARDS 和多器官功能障碍
- 批准号:
10739123 - 财政年份:2023
- 资助金额:
$ 127.81万 - 项目类别:
Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University
华盛顿大学传染病/免疫学促进住院医师研究 (ID/IMM StARR) 项目
- 批准号:
10592699 - 财政年份:2023
- 资助金额:
$ 127.81万 - 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
- 批准号:
10785755 - 财政年份:2023
- 资助金额:
$ 127.81万 - 项目类别: